Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Scalp microinfusion with dutasteride is a safe and promising treatment for male hair loss.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Baricitinib was effective in treating both early and late onset alopecia areata.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

N-acetylcysteine may help treat trichotillomania.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.